869984-24-7

Upstream product

• 135-02-4 ortho-anisaldehyde 
• 62717-78-6 2-(2-methoxyphenyl)oxirane 
• 24424-99-5 di-tert-butyl dicarbonate 
• 108343-90-4 2-amino-2-(2-methoxyphenyl)ethanol 

Downstream Products

• 869984-51-0 C₂₆H₂₆BrF₄N₃O₅ 
• 869984-48-5 C₂₈H₂₇BrF₄N₄O₅ 
• 869984-25-8 C₂₇H₂₈BrF₄N₃O₅ 

Relevant academic research and scientific papers

BICYCLIC HETEROCYCLIC COMPOUNDS AS INHIBITORS OFBCDIN3D ACTIVITY

The present invention relates to compounds that function as inhibitors and/or degraders of BCDIN3D activity. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to the

URACIL-TYPE GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATED THERETO

Compounds having utility as GnRH receptor antagonists and for treatment of a variety of sex-hormone related conditions in both men and women. Such compounds have the following structure (I): (I) wherein R1a, R1b, R1c, R2a, R2b, R3, R4, R5, R6, R7, n and X are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of structure (I) in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.